Relationship between the immune microenvironment of different locations in a primary tumour and clinical outcomes of oesophageal squamous cell carcinoma

被引:19
作者
Hatogai, Ken [1 ,2 ,3 ]
Fujii, Satoshi [1 ]
Kitano, Shigehisa [4 ]
Kojima, Takashi [2 ]
Daiko, Hiroyuki [5 ]
Yoshino, Takayuki [2 ]
Ohtsu, Atsushi [2 ]
Takiguchi, Yuichi [3 ]
Doi, Toshihiko [2 ]
Ochiai, Atsushi [1 ]
机构
[1] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Pathol, Kashiwa, Chiba, Japan
[2] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Chiba, Japan
[3] Chiba Univ, Grad Sch Med, Dept Med Oncol, Chuo Ku, Chiba, Japan
[4] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Dept Expt Therapeut, Tokyo, Japan
[5] Natl Canc Ctr Hosp East, Dept Esophageal Surg, Kashiwa, Chiba, Japan
关键词
INFILTRATING LYMPHOCYTES; FAVORABLE PROGNOSIS; PROGRAMMED DEATH-1; PD-L1; EXPRESSION; HETEROGENEITY; CANCER; QUANTIFICATION; PATHWAY; IMPACT;
D O I
10.1038/s41416-019-0622-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Tumour microenvironments can differ according to intratumoural locations. We investigated the immune status at different locations in primary tumours and its clinical significance in oesophageal squamous cell carcinoma (ESCC). METHODS: The number of CD8(+) tumour-infiltrating immune cells (TIICs) and PD-1(+) TIICs, and PD-L1 expression on tumour cells (PD-L1TC) were immunohistochemically examined in the surface (Surf), centre (Cent) and invasive front (Inv) of tumours surgically resected from 192 patients with ESCC. RESULTS: The PD-L1(+) rate was lower in Inv than in Cent (12.0% vs. 18.2%, P = 0.012), although the numbers of CD8+ TIICs and PD1(+) TIICs were comparable among intratumoural locations. High numbers of CD8(+) and PD-1(+) TIICs and positive PD-L1TC were related to better overall survival (OS) only in Surf and Cent (CD8: P = 0.012 in Surf, 0.018 in Cent, and 0.165 in Inv; PD-1: P = 0.028 in Surf, 0.021 in Cent, and 0.208 in Inv; and PD-L1: 0.044 in Surf, 0.026 in Cent, and 0.718 in Inv). Positive PD-L1TC in Surf and/or Cent but not in Inv demonstrated a strong tendency toward better OS (P = 0.053). CONCLUSIONS: Immune microenvironments according to the intratumoural location have different effects on the survival of patients with ESCC.
引用
收藏
页码:413 / 420
页数:8
相关论文
共 50 条
  • [1] The tumor immune microenvironment and its implications for clinical outcome in patients with oropharyngeal squamous cell carcinoma
    Gurin, Dominik
    Slavik, Marek
    Hermanova, Marketa
    Selingerova, Iveta
    Kazda, Tomas
    Hendrych, Michal
    Shatokhina, Tetiana
    Vesela, Marcela
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2020, 49 (09) : 886 - 896
  • [2] Tumour immune microenvironment in primary and metastatic papillary renal cell carcinoma
    Eich, Marie-Lisa
    Chaux, Alcides
    Rodriguez, Maria Angelica Mendoza
    Guner, Gunes
    Taheri, Diana
    Pena, Maria Del Carmen Rodriguez
    Sharma, Rajni
    Allaf, Mohamad E.
    Netto, George J.
    HISTOPATHOLOGY, 2020, 76 (03) : 423 - 432
  • [3] Analysis of Immune Microenvironment by Multiplex Immunohistochemistry Staining in Different Oral Diseases and Oral Squamous Cell Carcinoma
    Qiao, Bin
    Huang, Junwen
    Mei, Zi
    Lam, Alfred King-yin
    Zhao, Junfang
    Ying, Le
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [4] Effects of immune inflammation in head and neck squamous cell carcinoma: Tumor microenvironment, drug resistance, and clinical outcomes
    Zhu, Li
    Wang, Yue
    Yuan, Xingzhong
    Ma, Yifei
    Zhang, Tian
    Zhou, Fangwei
    Yu, Guodong
    FRONTIERS IN GENETICS, 2022, 13
  • [5] Comprehensive immunohistochemical analysis of tumor microenvironment immune status in esophageal squamous cell carcinoma
    Hatogai, Ken
    Kitano, Shigehisa
    Fujii, Satoshi
    Kojima, Takashi
    Daiko, Hiroyuki
    Nomura, Shogo
    Yoshino, Takayuki
    Ohtsu, Atsushi
    Takiguchi, Yuichi
    Doi, Toshihiko
    Ochiai, Atsushi
    ONCOTARGET, 2016, 7 (30) : 47252 - 47264
  • [6] Unravelling the difference of immune microenvironment characteristics between esophageal basaloid squamous cell carcinoma and conventional esophageal squamous cell carcinoma
    Jiang, Dongxian
    Xiao, Yuhao
    Yu, Zixiang
    Deng, Minying
    Song, Qi
    Huang, Jie
    Su, Jieakesu
    Xu, Chen
    Hou, Yingyong
    HUMAN PATHOLOGY, 2025, 155
  • [7] Immune checkpoint status and tumor microenvironment in vulvar squamous cell carcinoma
    Cocks, Margaret
    Chaux, Alcides
    Jenson, Erik G.
    Miller, James A.
    Rodriguez Pena, Maria Del Carmen
    Tregnago, Aline C.
    Taheri, Diana
    Eich, Marie-Lisa
    Sharma, Rajni
    Vang, Russell
    Netto, George J.
    VIRCHOWS ARCHIV, 2020, 477 (01) : 93 - 102
  • [8] Impacts of Cigarette Smoking on the Tumor Immune Microenvironment in Esophageal Squamous Cell Carcinoma
    Wang, Geng
    Pan, Chuqing
    Cao, Kexin
    Zhang, Jingbing
    Geng, Hui
    Wu, Kusheng
    Wen, Jing
    Liu, Caixia
    JOURNAL OF CANCER, 2022, 13 (02): : 413 - 425
  • [9] Tumour motion of oesophageal squamous cell carcinoma evaluated by cine MRI: associated with tumour location
    Zhou, H-Y
    Zhang, J-G
    Li, R.
    Zhang, X-M
    Chen, T-W
    Liu, N.
    Jiang, Y.
    Wu, L.
    CLINICAL RADIOLOGY, 2018, 73 (07) : 676.e1 - 676.e7
  • [10] The Prognostic Value of Immune Factors in the Tumor Microenvironment of Penile Squamous Cell Carcinoma
    Ottenhof, Sarah Rosanne
    Djajadiningrat, Rosa Sanne
    Thygesen, Helene Hoegsbro
    Jakobs, Pamela Josephine
    Jozwiak, Katarzyna
    Heeren, Anne Marijne
    de Jong, Jeroen
    Sanders, Joyce
    Horenblas, Simon
    Jordanova, Ekaterina Straschimirova
    FRONTIERS IN IMMUNOLOGY, 2018, 9